Release date: 2025-01-15 10:10:34 Article From: Lucius Laos Recommended: 120
Avatrombopag is a drug used to treat chronic liver disease and chronic immune thrombocytopenia, and its price has been a focus for patients and the medical community. This article will explore the market price of avatrombopag in detail, as well as the various factors that affect the price.
The price of avatrombopag varies by brand, size, region, and purchase channel, and this article will break down its price range in detail.
According to the latest market information, the price of avatrombopag in China is about US$600 to US$800, and the specific price is affected by various factors such as regional consumption level, drug specifications, manufacturers and brand types. For example, avatrombopag with a specification of 20mg/15 tablets costs about 7,140 yuan, while a 20mg/10 tablet price is about 4,760 yuan.
In addition to the original drug, there are several generic versions on the market, which are relatively low-priced. For example, the Indian version of avatrombopag, with a specification of 20mg*28 tablets, costs about $45 per box; Laos Lucius Edition, the price of the same specification is about $49 a box; The Bengal Yaopin International Edition is slightly more expensive, about $90 a box. These generics give patients more options in terms of price.
The price of avatrombopag is also affected by region and purchase channel. Factors such as market competition, consumption levels, and drug distribution channels in different regions will affect the final selling price of drugs. Some merchants or platforms will regularly launch promotional activities to attract consumers to buy, which will affect the price of drugs to a certain extent.
With the continuous improvement of medical policies and the intensification of market competition, the price of avatrombopag is expected to be more reasonable.
In recent years, with the strengthening of national supervision of drug prices and the continuous improvement of medical insurance policies, the price of avatrombopag has been reduced. In the future, as more generic drugs are launched and market competition intensifies, the price of avatrombopag is expected to decline further.
For patients, when purchasing avatrombopag, they should choose the appropriate drug specifications and purchase channels according to their own needs and actual conditions. Attention should be paid to checking the manufacturer, approval number and other information of the drug to ensure that the qualified drugs are purchased through formal channels. For drugs that are too low, you should be vigilant to avoid buying counterfeit and shoddy products.
Patients can also pay attention to the medical insurance policy to find out whether avatrombopag is included in the medical insurance list, and the specific reimbursement ratio. This helps to reduce the financial burden on patients and improve access to medications.
The price of avatrombopag is affected by a variety of factors, but with the continuous improvement of medical policies and the intensification of market competition, its price is expected to be more reasonable. When purchasing, patients should pay attention to price trends, choose appropriate purchase channels, and make full use of medical insurance policies to reduce their financial burden.
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:2012024-09-07
On November 14, 2024, the Committee for Medicinal Products for Human Use (CHMP) of the European Medi···【more】
Recommended:1582025-13-01
Recent advancements have reaffirmed the significance of liquid biopsy in the management of advanced ···【more】
Recommended:1562025-06-01
FDA Approves First Generic Version of Victoza (liraglutide injection)The U.S. Food and Drug Administ···【more】
Recommended:1712024-30-12
The new indication involves the treatment of adult patients with locally advanced, unresectable non-···【more】
Recommended:1612024-24-12
he U.S. Food and Drug Administration (FDA) has approved Crenessity (crinecerfont) for use in combina···【more】
Recommended:1462024-17-12
In the phase Ib/II multicenter pivotal FELIX study, the autologous 41BB-ζ anti-CD19 chimeric antigen···【more】
Recommended:1052024-13-12
On 25 July 2024, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHM···【more】
Recommended:2482024-26-08
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: